(1)
Mofid, B.; Razzaghdoust, A.; Ghajari, M. .; Basiri, A. .; Fattahi, M.-R. .; Houshyari, M. .; Jafari, A.; Taghizadeh-Hesary, F. Oncological Outcomes of Neoadjuvant Gemcitabine Plus Carboplatin Versus Gemcitabine Plus Cisplatin in Locally Advanced Bladder Cancer: A Retrospective Analysis: Neoadjuvant Carboplatin in Locally Advanced Bladder Cancer. Urol J 2022, 19, 371-378.